IL5 and breast cancer: Conversely, increased breast cancer IL-5 expression is associated with metastasis and poor prognosis [197], while others have found that tumour Th2 cell-derived IL-5 may instead enhance response to immune checkpoint inhibitors in breast cancer [198].